A company still losing money with growing sales, with elevated risk.
Going well
Sales up 12% in the latest quarter vs a year ago
Buying back shares: share count down 11% in 3 years
Little debt
Watch out for
About 5 months of cash left at its current burn
Losing money
Money moves
No insider buying or selling in the last 30 days
Institutions cut 0.3% from their holdings in the quarter ending June 2026 (61 bought, 50 sold)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$9.79+4.9% that day
Company value
$298M
Share price times all shares
Price vs sales
0.18x
No profit over the last year, so this compares value with sales instead
Cash vs value
8%
Cash as a share of company value
Debt vs value
22%
Debt as a share of company value
From TBI's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26
$443.0M+12% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $1.7B, up 10% from the 12 months before. Over 5 years, sales shrank about 2.6% a year.
What the price assumes
Your guesses, our math
Move the sliders to your own view of TBI. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
Sales in 5 years$2.7B
Profit in 5 years$272M
Price these guesses point to$164.57+1581% vs $9.79 todayAbout +76% a year, before dividends
What today's price needs: with a 10% margin and a 15x P/E, sales could shrink about 37% a year for 5 years and still match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.